A key market regulator for trade in the European Union has updated its guidelines to add plant-derived CBD as a legal ingredient in cosmetics.
The change comes after the European Industrial Hemp Association pointed out that the European Court of Justice recently ruled that CBD should not be classified as a drug and can be freely traded.
The classification change was made by the EU’s Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs (small- and medium-sized enterprises). Previously, only synthetic CBD was listed in the agency’s database.
Regulators list plant-derived CBD as a skin protectant and conditioner and note its function as an anti-oxidant.
“These are the types of news that make my day,” EIHA’s managing director, Lorenza Romanese, said in a statement.
Learn more about the European hemp market in this free report.
Medical Disclaimer:
The information provided in these blog posts is intended for general informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. The use of any information provided in these blog posts is solely at your own risk. The authors and the website do not recommend or endorse any specific products, treatments, or procedures mentioned. Reliance on any information in these blog posts is solely at your own discretion.
